Nebius’s quarterly sales were much higher than a year ago. The same release cycle told investors to expect the low end of the 2026 revenue range, because some revenue had moved into the first part of next year. I do not see a contradiction. The first number describes what the company already delivered and recognized. The second changes when management expects a portion of future sales to show up. A year-over-year growth rate cannot answer the timing question.
I would start by asking what still needs to happen between spending on a site and billing a customer. A delay is less costly if equipment payments also move back. It is more costly if the company has already committed the cash and waits longer for collections. Neither case can be inferred from a stock chart or from the revenue range alone. I want to see whether the timing change was isolated, and whether later filings show the deferred sales arriving.
NBIS against SPY
35 common trading sessions · first close = 100
View the closing-price data
| Date | NBIS | SPY |
|---|---|---|
| 2026-09-25 | $237.33 | $771.35 |
| 2026-09-28 | $231.88 | $765.61 |
| 2026-09-29 | $237.35 | $764.20 |
| 2026-09-30 | $235.88 | $762.63 |
| 2026-10-01 | $232.28 | $763.99 |
| 2026-10-02 | $242.81 | $769.64 |
| 2026-10-05 | $232.57 | $774.83 |
| 2026-10-06 | $249.87 | $779.09 |
| 2026-10-07 | $237.15 | $777.22 |
| 2026-10-08 | $219.71 | $773.93 |
| 2026-10-09 | $221.07 | $778.57 |
| 2026-10-12 | $210.06 | $778.10 |
| 2026-10-13 | $206.86 | $778.01 |
| 2026-10-14 | $186.01 | $769.60 |
| 2026-10-15 | $188.41 | $771.79 |
| 2026-10-16 | $165.47 | $763.25 |
| 2026-10-19 | $170.24 | $766.48 |
| 2026-10-20 | $171.45 | $769.05 |
| 2026-10-21 | $171.57 | $773.09 |
| 2026-10-22 | $159.17 | $763.96 |
| 2026-10-23 | $158.74 | $759.97 |
| 2026-10-26 | $153.27 | $765.37 |
| 2026-10-27 | $170.47 | $769.66 |
| 2026-10-28 | $182.34 | $772.31 |
| 2026-10-29 | $171.99 | $769.36 |
| 2026-10-30 | $154.14 | $755.72 |
| 2026-11-02 | $141.39 | $752.10 |
| 2026-11-03 | $151.64 | $754.35 |
| 2026-11-04 | $141.52 | $766.81 |
| 2026-11-05 | $120.37 | $733.00 |
| 2026-11-06 | $129.49 | $735.29 |
| 2026-11-09 | $141.45 | $752.69 |
| 2026-11-10 | $134.00 | $749.92 |
| 2026-11-11 | $154.69 | $759.81 |
| 2026-11-12 | $128.64 | $757.25 |
Management’s $12 billion to $13 billion 2027 revenue forecast is a useful benchmark, not a reason to declare the timing issue resolved. I would check the milestones that make the range possible: capacity made available, customer acceptance, billing and collections. If those steps move in sync, the delayed recognition looks more like timing. If expenses arrive first and cash receipts keep slipping, the same headline growth can come with a more demanding financing problem. That distinction matters more to me than whether the stock reverses Thursday’s loss.
| Measure | Reported figure | Context |
|---|---|---|
| Q3 revenue | $980.8 million | Reported consolidated revenue |
| 2026 revenue | $3.0–$3.4 billion | Management expects the low end |
| 2027 revenue | $12–$13 billion | Company forecast, not contracted cash |
